Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Arg1+ macrophages may play a role in causing alopecia areata.

A mutation in the IL2RA gene increases the risk of alopecia areata.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

AI can effectively predict COVID-19 mortality risk using patient data.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

AI chatbots can help with scabies education but shouldn't replace doctors.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Alopecia areata is now understood to be driven by genetic and immune factors.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The local environment significantly impacts Alopecia Areata.

Hair loss treatment caused more hair loss in a man.

Alopecia areata patients may have hearing loss linked to the condition's severity and duration.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Upadacitinib effectively treats severe alopecia areata and is safe.

CS12192 effectively treats alopecia areata with better safety than current options.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

A machine-learning test using hair can help detect autism early in infants.

AI can effectively detect hair and scalp disorders from images.

Alopecia areata causes hair loss and has various treatment options, but responses differ.